References
1a
Yue WS.
Li JJ.
Org. Lett.
2002,
2201
1b
Soldatenkov AT.
Polyanskii KB.
Soldatova SA.
Chem. Heterocycl. Compd.
2002,
38:
368
1c
New JS.
Christopher WL.
Yevich JP.
Butler R.
Schlemmer RF.
Van der Maelen CP.
Cipollina JA.
J. Med. Chem.
1989,
32:
1147
1d
Maffraund JP.
Eloy F.
Eur. J. Med. Chem. Chim. Ther.
1974,
483
1e
Podesta M.
Aubert D.
Furand JC.
Eur. J. Med. Chem. Chim. Ther.
1974,
487
1f Makikado T. inventors; Japanese Patent 7015985.
; Chem. Abstr. 1970, 73, 77220
1g Makikado T. inventors; Japanese Patent 7033655.
; Chem. Abstr. 1971, 74, 76400
1h Simpson WRJ. inventors; Ger. Offen 2350387.
; Chem. Abstr. 1974, 81, 13555
1i inventors; Centre d’Etudes de l’Industrie Pharmaceutique. Ger. Offen 2404308.
; Chem. Abstr. 1974, 81, 316131
2a
Lhommet G.
Sliwa H.
Maitte P.
Bull. Soc. Chim. Fr.
1972,
1442
2b
Bisagni E.
Civier A.
Marquet J.-P.
J. Heterocycl. Chem.
1975,
12:
461
2c
Abramovitch RA.
Deep A.
Kishore D.
Mpango GBW.
Gazz. Chim. Ital.
1988,
118:
167
2d
Hörlein G.
Kübel B.
Studeneer A.
Salbeck A.
Liebigs Ann. Chem.
1979,
371
2e
Shiotani S.
Morita H.
Ishida T.
Iu Y.
J. Heterocycl. Chem.
1988,
25:
1205
2f
Moron J.
Nguyen CH.
Bisagni E.
J. Chem. Soc., Perkin Trans. 1
1983,
225
3a
Eloy F.
Deryckere A.
Bull. Soc. Chim. Fr.
1971,
1442
3b
Eloy F.
Deryckere A.
J. Heterocycl. Chem.
1971,
8:
57
3c
Bouzart JD.
Bisagni E.
Bull. Soc. Chim. Fr.
1971,
1727
3d
Molina P.
Fresneda PM.
Hurtado F.
Synthesis
1987,
45
3e
Krutosikova A.
Dandarova M.
Chilova J.
Vegh D.
Monatsh. Chem.
1992,
123:
807
3f
Korenova A.
Krutosikova A.
Kovac J.
Celec S.
Coll. Czech. Chem. Commun.
1987,
52:
192
3g
Bobosik V.
Krutosikova A.
Jordis U.
Monatsh. Chem.
1995,
126:
747
4a
Khlebnikov AF.
Novikov MS.
Kostikov RR.
Russ. Chem. J.
1999,
43:
70
4b
Novikov MS.
Khlebnikov AF.
Sidorina ES.
Kostikov RR.
J. Fluorine Chem.
1998,
90:
117
4c
Novikov MS.
Khlebnikov AF.
Krebs A.
Kostikov RR.
Eur. J. Org. Chem.
1998,
133
4d
Novikov MS.
Khlebnikov AF.
Sidorina ES.
Kostikov RR.
J. Chem. Soc., Perkin Trans. 1
2000,
231
4e
Novikov MS.
Khlebnikov AF.
Besedina OV.
Kostikov RR.
Tetrahedron Lett.
2001,
42:
533
4f
Voznyi IV.
Novikov MS.
Khlebnikov AF.
Kopf J.
Kostikov RR.
J. Chem. Soc., Perkin Trans. 1
2002,
1628
4g
Novikov MS.
Khlebnikov AF.
Shevchenko MV.
J. Fluorine Chem.
2003,
123:
177
4h
Khlebnikov AF.
Novikov M.
Amer AA.
Tetrahedron Lett.
2002,
43:
8523
5a
Khlebnikov AF.
Novikov MS.
Kostikov RR.
Adv. Heterocycl. Chem.
1996,
65:
93
5b
Novikov MS.
Khlebnikov AF.
Masalev AE.
Kostikov RR.
Tetrahedron Lett.
1997,
38:
4187
5c
Novikov MS.
Khlebnikov AF.
Sidorina ES.
Masalev AE.
Kopf J.
Kostikov RR.
Russ. J. Org. Chem.
2002,
38:
672
5d
Novikov MS.
Khlebnikov AF.
Kostikov RR.
Russ. J. Org. Chem.
2002,
38:
1647
6a
McCarthy JR.
Barney CL.
O’Donnell MJ.
Huffman JC.
J. Chem. Soc., Chem. Commun.
1987,
469
6b
Khlebnikov AF.
Novikov MS.
Kostikov RR.
Mendeleev Commun.
1997,
145
7a
Berg-Nielson K.
Acta Chem. Scand., Ser. B
1977,
B31:
224
7b
Khlebnikov AF.
Kostik EI.
Kostikov RR.
Chem. Heterocycl. Compd.
1991,
636
7c
Romashin YN.
Liu MTH.
Nijjar SS.
Attanasi OA.
Chem. Commun.
2000,
1147
7d
Bonneaua R.
Romashin YN.
Liu MTH.
J. Photochem. Photobiol., A
1999,
126:
31
7e
Bonneau R.
Romashin YN.
Liu MTH.
MacPherson SE.
J. Chem. Soc., Chem. Commun.
1994,
509
7f
Liu MTH.
Romashin YN.
Bonneau R.
Int. J. Chem. Kin.
1994,
26:
1179
8a
Romashin YN.
Liu MTH.
Bonneau R.
Chem. Commun.
1999,
447
8b
Romashin YN.
Liu MTH.
Ma W.
Moss RA.
Tetrahedron Lett.
1999,
40:
7163
9a
Taylor EC.
Turchi IJ.
Chem. Rev.
1979,
79:
181
9b
Baldwin JE.
Pudussery RG.
Qureshi AK.
Sklarz B.
J. Am. Chem. Soc.
1968,
90:
5325
10
Pinter A.
Nyerges M.
Viranyi A.
Töke L.
Tetrahedron Lett.
2003,
44:
2345
11
General Procedure for Preparation of Compounds 3 and 4.
A flask containing active lead (1.2 g, 5.8 mmol) and CH2Cl2 (7 mL) was charged with Bu4NBr (2.0 g, 6.0 mmol), imine 1a-f (2.7 mmol), and CBr2F2 (1.95 g, 9.3 mmol). The flask was tightly stopped, and the mixture was irradiated with ultrasound at 40 °C until the lead was completely consumed. Chromatography (hexane-EtOAc, 4:1) followed by recrystallization provided compounds 4 or/and 3.
5-(4-Bromophenyl)-4,4,6,6-tetrafluoro-2-(2-fluoro-phenyl)-4,5,5a,6-tetrahydro-3a
H
-cyclo-propa[
b
]fu-ro[2,3-
c
]pyrrole (
3d): mp 135-140 °C dec. (hexane-Et2O). 1H NMR (300 MHz, CDCl3): δ = 3.88 (t, J
HF = 7.3 Hz, 1 H, 5a-H), 4.60 (dddd, J = 13.3, 6.4, 3.9, 2.6 Hz, 1 H, 3a-H), 5.93 (dd, J = 3.9, 2.6 Hz, 1 H, 3-H), 7.01-7.69 (m, 8 H, Ar-H). 13C NMR (75 MHz, CDCl3): δ = 50.5 (t, J
CF = 15.5 Hz, 1a-C), 58.4 (t, J
CF = 32.1 Hz, 3a-C), 70.0 (m, 6a-C), 98.0 (d, J
CF = 14.4 Hz, 3-C), 109.7 (ddd, J
CF = 320, 302, 9.4 Hz, 6-C), 115.3, 115.6 (d, J
CF = 21.6 Hz), 116.6 (d, J
CF = 11.6 Hz), 118.4, 123.9 (d, J
CF = 3.9 Hz), 127.3 (d, J
CF = 1.7 Hz, CAr), 128.6 (ddd, J
CF = 260, 247, 5.5 Hz, 4-C), 130.9 (d, J
CF = 8.8 Hz), 131.8, 137.7 (d, J
CF = 5.0 Hz, CAr), 152.7 (2-C), 159.9 (d, J
CF = 254 Hz, CAr-F). Anal. Calcd for C19H11BrF5NO: C, 51.38; H, 2.50; N 3.15. Found: C, 51.41; H, 2.75; N, 2.92.
6,6-Difluoro-5-phenyl-5a,6-dihydro-3a
H
-cyclo-propa[
b
]furo[2,3-
c
]pyrrol-4 (5
H
)-one (
4a): mp 87-88 °C (hexane-Et2O). IR (CHCl3): 1725 (C=O) cm-1. 1H NMR (300 MHz, CDCl3): δ = 3.96 (dd, 3
J HF = 8.2, 1.7 Hz, 1 H, 5a-H), 4.22 (dd, J = 4.5, 2.6 Hz, 1 H, 3a-H), 5.54 (dd, J = 4.5, 2.6 Hz, 1 H, 3-H), 6.62 (t, J = 2.6 Hz, 1 H, 2-H), 7.23-7.54 (m, 5 H, Ph-H). 13C NMR (75 MHz, CDCl3): δ = 49.5 (dd, J
CF = 17.7, 15.5 Hz, 5a-C), 51.6 (d, J
CF = 1.7 Hz, 3a-C), 68.2 (dd, J
CF = 19.4, 11.1 Hz, 6a-C), 100.4 (d, J
CF = 1.1 Hz, 3-C), 108.5 (dd, J
CF = 319, 301 Hz, 6-C), 120.7, 125.7, 128.8, 137.3 (CPh), 147.5 (2-C), 170.8 (dd, J
CF = 3.9, 3.2 Hz, 4-C). Anal. Calcd for C13H9F2NO2: C, 62.65; H, 3.64; N, 5.62. Found: C, 62.64; H, 3.82, N, 5.73.
12
General Procedure for Preparation of Compounds 8.
Compound 3 or 4 (0.52 mmol) is placed to a dry, 10 mL, one-necked round-bottomed flask and is heated at 160 °C for 10 min. Upon cooling to r.t. a brown solid forms; recrystallization from CH2Cl2-Et2O mixture gives furo[3,2-c]pyridine 8 as a colorless solid.
7-Fluoro-5-phenylfuro[3,2-
c
]pyridine-4 (5
H
)-one (
8a): mp 120-121 °C (CH2Cl2-Et2O). IR (CHCl3): 1630 (C=C), 1705 (C=O) cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.07 (dd, J
HH = 2.0 Hz, J
HF = 2.3 Hz, 1 H, 3-H), 7.28 (d, J
HF = 5.9 Hz, 1 H, 6-H), 7.39-7.52 (m, 5 H, Ar-H), 7.63 (d, 1 H, J
HH = 2.0 Hz, 2-H). 13C NMR (75 MHz, CDCl3): δ = 108.2 (d, J
CF = 2.2 Hz, 3-C), 117.5 (d, J
CF = 3.3 Hz, 3a-C), 119.7 (d, J
CF = 32.6 Hz, 6-C), 126.5, 128.1, 129.0 (CAr), 137.8 (d, J
CF = 239 Hz, 7-C), 140.0 (CAr), 144.6 (2-C), 148.9 (d, J
CF = 15.5 Hz, 7a-C), 156.9 (4-C). Anal. Calcd for C13H8FNO2: C, 68.12; H, 3.52; N 6.11. Found: C, 67.96; H, 3.55; N 6.08.